GATC Biotech Launches One-Week Diagnostic Exome, but Clinical Interpretation is Pending | GenomeWeb

Aiming to get a foothold in the emerging clinical next-gen sequencing market in Europe, GATC Biotech of Germany earlier this month launched a one-week diagnostic exome sequencing service designed to "meet the varied requirements of clinicians."

While the company performs the service worldwide under the European EN ISO/IEC 17025 standard, which it says is similar to the CLIA laboratory standards in the US, it does not currently provide clinical interpretation of the results, which it plans to add in the future.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

Prosecutors seek to introduce evidence from low-template DNA analysis in a murder case in upstate New York, the New York Times reports.

In PNAS this week: map of UV-induced damage in yeast genome, comparative epigenomics uncovers plant lacking key DNA methyltransferase enzyme, and more.

Researchers kick off their second Queer in STEM survey to examine what can make STEM careers welcoming, Wired reports.

A startup company is offering a test to analyze soil samples from farms for pathogens.